BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...

Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

China: A recent study highlights the potential risks associated with sarcopenic obesity (SO) in diabetic patients with heart ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure.

Out-of-hospital cardiac arrest (OHCA) in people experiencing a heart attack is a time-dependent medical emergency requiring ...

Living with a heart that struggles to pump effectively creates daily challenges for millions of Americans. Systolic heart ...

AI-assisted diagnosis of asymptomatic left ventricular dysfunction may detect disease early and thereby expedite treatment of ...

Berlin: Bayer has announced that the Company has received Priority Review designation from the U.S. Food and Drug ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death ...